AMANTADINE HYDROCHLORIDE
| Brand name | GOCOVRI |
|---|---|
| Active ingredient | AMANTADINE HYDROCHLORIDE |
| Strength | EQ 137MG BASE |
| Dosage form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | August 2017 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12233033 | August 2038 | use U-3180 |
| 11065213 | August 2038 | product |
| 11077073 | August 2038 | use U-2106 |
| 10154971 | December 2034 | use U-2459 |
| 10646456 | June 2034 | use U-2808 |
| 11903908 | June 2034 | use U-3822 |
| 11197835 | December 2030 | use U-2106 |
| 9867791 | December 2030 | use U-2106 |
| 9877933 | December 2030 | use U-2224 |
| 9867793 | December 2030 | use U-2106 |
| 8741343 | December 2030 | use U-2106 |
| 9867792 | December 2030 | use U-2106 |
| 8389578 | January 2028 | use U-2105 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.